Ephed Plus is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Dickey Consumer Products Dba Dmd. The primary component is Ephedrine Hydrochloride; Guaifenesin.
| Product ID | 65193-225_8aab699e-b057-43b0-a369-1db5b5d91fb5 |
| NDC | 65193-225 |
| Product Type | Human Otc Drug |
| Proprietary Name | Ephed Plus |
| Generic Name | Ephedrine Hydrochloride, Guaifenesin |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2019-04-02 |
| Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Labeler Name | Dickey Consumer Products DBA DMD |
| Substance Name | EPHEDRINE HYDROCHLORIDE; GUAIFENESIN |
| Active Ingredient Strength | 25 mg/1; mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2019-04-02 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | OTC monograph final |
| Application Number | part341 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2019-04-02 |
| Ingredient | Strength |
|---|---|
| EPHEDRINE HYDROCHLORIDE | 25 mg/1 |
| SPL SET ID: | b8a72b61-1bf7-4bc4-9638-225b902204b8 |
| Manufacturer | |
| UNII | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 65193-225 | Ephed Plus | ephedrine hydrochloride, guaifenesin |
| 65193-320 | Ephed Asthma | ephedrine hydrochloride, guaifenesin |
| 65193-340 | Red Label Ephed Plus | ephedrine hydrochloride, guaifenesin |
| 65193-125 | Red Label Ephedrine Plus | ephedrine hydrochloride, guaifenesin |
| 70258-320 | VASOPRO EPHEDRINE | EPHEDRINE HYDROCHLORIDE, GUAIFENESIN |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() EPHED PLUS 86629967 4873972 Live/Registered |
Dickey Investments, L.L.C. 2015-05-14 |
![]() EPHED PLUS 76495797 2952572 Dead/Cancelled |
DICKEY INVESTMENTS, LLC 2003-03-06 |
![]() EPHED PLUS 76346793 2784790 Live/Registered |
DICKEY INVESTMENTS, LLC 2001-12-07 |